1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell LymphomaB-cell Lymphoma Recurrent; B-cell Lymphoma Refractory; NK CellNot yet recruitingPhase 1 / Phase 22023-06-22NCT05909098